Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chalcogenide substitution for the synthesis of dye MSe5: a benzoselenadiazole photosensitizer for high-performance DSSCs.

Chemical science·2026
Same author

The Anthranil Core as a π-Conjugated Bridge in the Synthesis of Molecular Photosensitizers.

The Journal of organic chemistry·2025
Same author

Chemical and Enzymatic Mechanosynthesis of Organocatalytic Peptide Materials Based on Proline and Phenylalanine.

ChemSusChem·2025
Same author

Exploring quinoline-type inhibitors of ergosterol biosynthesis: Binding mechanism investigation via molecular docking, pharmacophore mapping, and dynamics simulation approaches.

Computers in biology and medicine·2024
Same author

Correction: Influence of the carbazole moiety in self-assembling molecules as selective contacts in perovskite solar cells: interfacial charge transfer kinetics and solar-to-energy efficiency effects.

Nanoscale advances·2024
Same author

Exploring acetaminophen prodrugs and hybrids: a review.

RSC advances·2024

Related Experiment Video

Updated: May 10, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Cantharidin-based small molecules as potential therapeutic agents.

Carlos E Puerto Galvis1, Leonor Y Vargas Méndez, Vladimir V Kouznetsov

  • 1Laboratorio de Química Orgánica y Biomolecular, Escuela de Química, Universidad Industrial de Santander, A.A. 678, Bucaramanga, Colombia.

Chemical Biology & Drug Design
|July 2, 2013
PubMed
Summary

This review covers cantharidin-based small molecules, focusing on their synthesis, chemical transformations, and biological activities. These compounds show promise in cancer treatment by inhibiting phosphoprotein phosphatases.

Keywords:
Diels-Alder cycloaddition reactionsanticancer activityblister beetlescantharidin analogsdrug design and developmentprotein phosphatases inhibitory activity

More Related Videos

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Related Experiment Videos

Last Updated: May 10, 2026

Protein Target Prediction and Validation of Small Molecule Compound
10:21

Protein Target Prediction and Validation of Small Molecule Compound

Published on: February 23, 2024

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background:

  • Cantharidin, a natural product from blister beetles, and its derivatives have garnered interest for their therapeutic potential.
  • Recent research (2006-2012) has expanded the understanding of cantharidin-based small molecules and their metabolites.
  • The inhibitory activity of phosphoprotein phosphatases is a key mechanism explored for cancer treatment.

Purpose of the Study:

  • To review and synthesize recent findings on the chemistry and pharmacology of cantharidin-based small molecules.
  • To summarize the synthetic strategies and chemical modifications of cantharidin analogs.
  • To highlight the biological activities, particularly the anti-cancer potential via phosphoprotein phosphatase inhibition.

Main Methods:

  • Literature review of scientific publications from 2006-2012.
  • Analysis of synthetic routes and chemical transformations of cantharidin and its analogs.
  • Evaluation of reported biological activities, focusing on enzyme inhibition.

Main Results:

  • Compilation of diverse synthetic approaches for cantharidin, norcantharidin, cantharidimide, and norcantharimide analogs.
  • Detailed discussion of chemical transformations leading to novel derivatives.
  • Evidence supporting the inhibitory effects of these analogs on phosphoprotein phosphatases.

Conclusions:

  • Cantharidin-based small molecules represent a promising class of compounds for drug discovery.
  • Further research into these analogs could lead to the development of new small molecule modulators for cancer therapy.
  • Understanding their mechanism of action, particularly phosphatase inhibition, is crucial for future drug design.